Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Liège, Belgium, January 08, 2021 – More info here
CONTACT
Imcyse S.A.
Denis Bedoret
Chief Executive Officer
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
FOR MEDIA INQUIRES:
MC Services AG
Anne Hennecke / Brittney Sojeva
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel.: +49 (0) 211-529-252-14